drugset / Trial / NCT00720148
A Phase I Trial of Bortezomib and Sunitinib
Phase 1
Completed
30 enrolled
Emory University
Millennium Pharmaceuticals, Inc. · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the effect of the combination of sunitinib and bortezomib. We will see what effects it has on your cancer and find the highest dose of each agent that can be given without causing severe side effects.
Timeline
- Start
- 2008-02
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | Intravenous |
| Subject | Sunitinib | Small molecule | — | Oral |